Sepsis remains a common and deadly condition that occurs when the body reacts to an infection in the bloodstream. Scientists
Path to deadly sepsis varies by bacterial infection
Diabetes may begin more than 20 years before diagnosis
Early signs of type 2 diabetes can be identified more than 20 years before diagnosis, according to new research presented
Total ankle arthroplasty offers patients greater range of motion and less pain
Surgical reconstruction is a life changer for people with end-stage ankle arthritis, a painful condition that limits patients’ abilities to
Long-term effectiveness of therapy for common cause of kidney failure
New research provides support for the long-term efficacy of a drug used to treat in patients with autosomal dominant polycystic
Why randomized trials for proton therapy are difficult to complete (and what we can do about it): Experts lay out strategies to tackle key barriers in proton research
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new therapies with
Under pressure: The surgeon’s conundrum in decision making: Small study based on subjective interviews explores decision-making process in life-and-death emergencies
In a small study based on conversations with 20 hospital-based surgeons, Johns Hopkins researchers say they found that most report
Self-monitoring of type 2 diabetes reduces follow-up costs by more than half
Self-monitoring of type 2 diabetes used in combination with an electronic feedback system results in considerable savings on health care
Complication of ‘fat freezing’ procedure may be more common than thought
Cryolipolysis is a noninvasive cosmetic procedure that eliminates excess fat by freezing it. But a complication called paradoxical adipose hyperplasia
Study with implications for opioid crisis finds opioids raise risk of fracture nonunion
Dr. Robert Zura, Professor and Chair of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of
What would help or hinder patient participation in mitochondrial disease clinical trials? Patient-centric perspective offers key insights into upcoming treatment studies
As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study